Benitec Biopharma Inc. cotiza a 8.78 USD y tiene una capitalización bursátil de $306M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines in the United States. Its Silence and Replace, a DNA-directedRNA interference platform, that combines RNA interference with gene therapy to create medicines which simultaneously facilitate sustained sil…
| Periodo | 2026-11 | 2026-09 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.26 | $-0.24 | $-0.26 |
| Estimado | $-0.28 | $-0.26 | $-0.28 | $-0.23 |
| Sorpresa | — | +0.0% | +14.3% | -13.0% |
| Métrica | BNTC | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -25.7% | -40.4% | +14.7% |
| ROA | -24.9% | -32.0% | +7.1% |
| Current Ratio | 34.00 | 2.84 | +31.16 |
| Debt / Equity | — | 0.28 | — |